000 01392 a2200421 4500
005 20250517064124.0
264 0 _c20161213
008 201612s 0 0 eng d
022 _a1365-2133
024 7 _a10.1111/bjd.14311
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKai, A C
245 0 0 _aFive-year recurrence rate of lentigo maligna after treatment with imiquimod.
_h[electronic resource]
260 _bThe British journal of dermatology
_cJan 2016
300 _a165-8 p.
_bdigital
500 _aPublication Type: Clinical Study; Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAminoquinolines
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aFacial Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aHutchinson's Melanotic Freckle
_xdrug therapy
650 0 4 _aImiquimod
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xetiology
650 0 4 _aSkin Neoplasms
_xdrug therapy
700 1 _aRichards, T
700 1 _aColeman, A
700 1 _aMallipeddi, R
700 1 _aBarlow, R
700 1 _aCraythorne, E E
773 0 _tThe British journal of dermatology
_gvol. 174
_gno. 1
_gp. 165-8
856 4 0 _uhttps://doi.org/10.1111/bjd.14311
_zAvailable from publisher's website
999 _c25474489
_d25474489